HAYWARD, Calif. — Impax Labs has appointed a new president of its generic pharmaceutical division.
The drug maker said that Carole Ben-Maimon will be responsible for expanding the generic business. Recently, Ben-Maimon served as Qualitest Pharmaceuticals' SVP corporate strategy consulting. Additionally, she served as the chairman of the board of the Generic Pharmaceutical Association from 2000 to 2003.
Ben-Maimon will report to Impax's president and CEO Larry Hsu.